Home | Advisory Board | Our Team | About Wadsworth | DermaLOC | News & Events

About Wadsworth

bannersm2a.jpg

History

DermaLOCTM grew out of an entry to the MIT 50K competition in 2005.  The two surgeon founders recognized a market need for a needleless, painless and inexpensive method to treat traumatic lacerations and surgical incisions. The roots of the present methods of wound closure precede written history and the more recent entrants to the market have been met with significant resistance - due in part to their inability to demonstrate durability and effacacy.

In April of 2009, Wadsworth Medical Technologies was one of seven companies to win Accelerator Loan from the Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing Massachusetts' Life Sciences Initiative. Eighty-eight companies applied for the program, which was overseen by the Center's Scientific Advisory Board.  In later 2010, Wadsworth Medical Technologies was awarded an IRS/Theraputic Grant Award.

On a personal note, one of our founders, Andrew D. Fox, MD, former Professor of Vascular Surgery, relates: I fell through plate glass when I was 6 years old and am still haunted by the experience of being brought to the emergency room - where two nurses held me down while a doctor stuck me with a burning syringe of novocaine and then placed a dozen or so sutures.  Though the physical scar has long since faded, to this day, I sitll shudder with the memories of anxiety, fear, and pain associated with that trip to the emergency room. 
The fundamental standard approach to wound closure is now changed by DermaLOC.

Our Mission

It is our mission to provide patients and hospital personnel with medical devices that are easy to use and gentle for patients.  DermaLOC allows all users to obtain the operative results of a seasoned plastic surgeon with essentially no learning curve or transition costs.

Powered by Register.com